PGNX Progenics Pharmaceuticals Inc

CUSIP NO. 743187106                                    13G

 1  NAME OF REPORTING PERSON
    S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
      Eagle Asset Management, Inc.      59-2385219

 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*  (A) ______
                                                      (B) ______

 3  SEC USE ONLY

 4 CITIZENSHIP OR PLACE OF ORGANIZATION

   State of Florida

        NUMBER OF             5   SOLE VOTING POWER
         SHARES                           0
      BENEFICIALLY            6   SHARED VOTING POWER
         OWNED                             - - -
         AS OF
         03/31/20            7  SOLE DISPOSITIVE POWER
        BY EACH                           0
       REPORTING              8   SHARED DISPOSITIVE POWER
      PERSON WITH                      - - -

 9  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

             0

10    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
                                                  [_____]

11  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

              0%

12  TYPE OF REPORTING PERSON*

            IA

Page 2 of 5 Pages









Item 1(a)       Name of Issuer:

                Progenics Pharmaceuticals, Inc.



Item 1(b)       Address of Issuer's Principal Executing Offices:

                One World Trade Center, 47th Floor
                New York, NY  10007




Item 2(a)       Name of Person Filing:

                Eagle Asset Management, Inc.


Item 2(b)       Address of Principal Business Office:

                880 Carillon Parkway
                St. Petersburg, Florida  33716


Item 2(c)       Citizenship:

                Florida


Item 2(d)       Title of Class of Securities:

                Common Stock


Item 2(e)       CUSIP Number:

                743187106


Item 3          Type of Reporting Person:

(e) Investment  Adviser  registered  under Section 203 of the Investment
Advisors Act of 1940



Page 3 of 5 Pages




Item 4          Ownership as of 03/31/20

         (a)    Amount Beneficially Owned:

               0 shares of common stock beneficially owned including:

                 No. of Shares
                 Eagle Asset Management, Inc.                   0

          (b)   Percent of Class:                               0


         (c)    Deemed Voting Power and Disposition Power:

                (i)             (ii)                (iii)         (iv)
                                                  Deemed          Deemed
                Deemed         Deemed             to have         to have
                to have        to have            Sole Power      Shared Power
                Sole Power     Shared Power       to Dispose      to Dispose
                to Vote or     to Vote or         or to           or to
                to Direct      to Direct          Direct the      Direct the
                to Vote        to Vote            Disposition     Disposition

Eagle Asset     0       ----                     0        ----
Management, Inc.


Item 5          Ownership of Five Percent or Less of a Class:

                 If  this  statement is being filed to report the  fact that
as of the date hereof the reporting person has ceased to  be the  beneficial
owner of more than five percent of the  class  of securities, check the
following.
                (X)

Item 6          Ownership of More than Five Percent on Behalf of Another Person:

                 N/A

Item 7          Identification and Classification of the Subsidiary which Acquired
                the Security Being Reported on by the Parent Holding Company:

                 N/A

Page 4 of 5 Pages






Item 8          Identification and Classification of  Members  of the Group:   N/A


Item 9          Notice of Dissolution of Group:   N/A


Item 10         Certification:

                By  signing  below I certify that to the  best  of  my
knowledge  and  belief,  the securities referred  to  above  were acquired
in the ordinary course of business and were not acquired for  purpose  of
and  do  not have the  effect  of  changing  or influencing the control of
the issuer of such securities and were not  acquired  in  connection with
or as  a  participant  in  any transaction having such purposes or effect.

                Signature


         After  reasonable  inquiry  and  to  the  best  of  my knowledge
and belief, I certify that the information set forth in this statement is
true, complete and correct.

Date: 06/01/20                          EAGLE ASSET MANAGEMENT, INC.



                                        _________________________________
                                        Damian Sousa
                                        Vice President
                                        Chief Compliance Officer





Page 5 of 5 Pages